Concepedia

Laure Lacoin

LL

Statistics

Publications

12

Citations

268

H-Index

11

Active since

2012

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Belgium)

IQVIA (United Kingdom)

Bristol-Myers Squibb (United Kingdom)

IPO Porto

Laure Lacoin is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacoepidemiology, and drug safety.

Top concepts

Publications per year

2012–2022

12

Publications

12

Evolving landscape of stroke prevention in atrial fibrillation within the UK between 2012 and 2016: a cross-sectional analysis study using CPRD

Laure Lacoin, Matthew Lumley, Essra Ridha et al. · BMJ Open · 2017 · 41 citations · Full text

Real-world treatment patterns and survival outcomes for advanced non-small cell lung cancer in the pre-immunotherapy era in Portugal: a retrospective analysis from the I-O Optimise initiative

Marta Soares, Luís Antunes, Patrícia Redondo et al. · BMC Pulmonary Medicine · 2020 · 28 citations · Full text

I-O Optimise: A Novel Multinational Real-World Research Platform In Thoracic Malignancies

Simon Ekman, Frank Griesinger, Paul Baas et al. · Future Oncology · 2019 · 27 citations · Full text

Trends in treatment patterns and survival outcomes in advanced non-small cell lung cancer: a Canadian population-based real-world analysis

Robert Carroll, Margherita Bortolini, Alan Calleja et al. · BMC Cancer · 2022 · 27 citations · Full text

Treatment patterns and outcomes for patients with malignant pleural mesothelioma in England in 2013–2017: A nationwide CAS registry analysis from the I-O Optimise initiative

Paul Baas, M. Daumont, Laure Lacoin et al. · Lung Cancer · 2021 · 26 citations · Full text

1–5 of 12